We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+9.56%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$812M
AUM Growth
+$219M
(+37%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
21.28%
Top 10 Holdings %
Top 10 Hldgs %
42.3%
Holding
3,095
New
215
Increased
1,249
Reduced
951
Closed
267
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$9.74M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.67M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$7.37M |
| 4 |
Apple
AAPL
|
+$6.37M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$5.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.33M |
| 2 |
MGI
MoneyGram International, Inc. New
MGI
|
+$1.19M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$774K |
| 4 |
FLG
Flagstar Bank National Association
FLG
|
+$531K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$438K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Technology | 11.11% |
| 3 | Healthcare | 9.24% |
| 4 | Industrials | 3.53% |
| 5 | Consumer Staples | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Applovin
APP
$116B
| $4.23K | ﹤0.01% |
402
+392
| +3,920% | +$5.75K |
|
1902
Generac Holdings
GNRC
$12.5B
| $4.23K | ﹤0.01% |
42
-115
| -73% | -$13K |
|
|
AZEK
1903
DELISTED
The AZEK Co
AZEK
| $4.23K | ﹤0.01% |
208
+185
| +804% | +$3.42K |
|
1904
Travel + Leisure Co
TNL
$4.7B
| $4.22K | ﹤0.01% |
116
+62
| +115% | +$2.32K |
|
1905
Winnebago Industries
WGO
$909M
| $4.22K | ﹤0.01% |
80
-13
| -14% | -$739 |
|
1906
Four Corners Property Trust
FCPT
$2.75B
| $4.2K | ﹤0.01% |
162
+96
| +145% | +$2.47K |
|
|
FOLD
1907
DELISTED
Amicus Therapeutics
FOLD
| $4.2K | ﹤0.01% |
344
-117
| -25% | -$1.32K |
|
|
INDT
1908
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $4.19K | ﹤0.01% |
+66
| New | +$3.75K |
|
1909
Harmony Biosciences
HRMY
$2.24B
| $4.19K | ﹤0.01% |
76
-61
| -45% | -$3.35K |
|
1910
Agios Pharmaceuticals
AGIO
$1.93B
| $4.18K | ﹤0.01% |
149
+37
| +33% | +$1.04K |
|
1911
Invesco Mortgage Capital
IVR
$805M
| $4.17K | ﹤0.01% |
328
+308
| +1,540% | +$3.77K |
|
|
MRTX
1912
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $4.17K | ﹤0.01% |
92
-79
| -46% | -$5.11K |
|
1913
Global Net Lease
GNL
$1.95B
| $4.16K | ﹤0.01% |
331
+80
| +32% | +$992 |
|
1914
Cogent Biosciences
COGT
$7.24B
| $4.15K | ﹤0.01% |
359
| – | – |
|
1915
Xerox
XRX
$425M
| $4.15K | ﹤0.01% |
+284
| New | +$4.28K |
|
1916
Grand Canyon Education
LOPE
$3.98B
| $4.12K | ﹤0.01% |
+39
| New | +$3.89K |
|
|
P
1917
Everpure Inc
P
$29.9B
| $4.12K | ﹤0.01% |
154
+65
| +73% | +$1.89K |
|
1918
SPS Commerce
SPSC
$2.64B
| $4.11K | ﹤0.01% |
32
-14
| -30% | -$1.8K |
|
1919
Horizon Bancorp
HBNC
$1.04B
| $4.09K | ﹤0.01% |
271
-387
| -59% | -$6.38K |
|
1920
Ashland
ASH
$3.5B
| $4.09K | ﹤0.01% |
38
| – | – |
|
1921
Hyatt Hotels
H
$16.7B
| $4.07K | ﹤0.01% |
45
-215
| -83% | -$19.7K |
|
1922
Vanda Pharmaceuticals
VNDA
$302M
| $4.07K | ﹤0.01% |
550
-96
| -15% | -$935 |
|
|
AIMC
1923
DELISTED
Altra Industrial Motion Corp
AIMC
| $4.06K | ﹤0.01% |
68
-47
| -41% | -$2.47K |
|
1924
Cullinan Oncology
CGEM
$1.14B
| $4.06K | ﹤0.01% |
385
+207
| +116% | +$2.52K |
|
1925
LivaNova
LIVN
$4.2B
| $4.05K | ﹤0.01% |
73
+53
| +265% | +$2.71K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Lindbrook Capital held 3,095 positions worth $812M, up 37% from $593M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Lindbrook Capital deployed $173M of net new capital in Q4 2022, opening 215 new positions and adding to 1,249 existing holdings. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $1.33M trimmed.
- Lindbrook Capital's largest Q4 2022 buy was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q4 2022, an estimated $9.74M increase.
- Lindbrook Capital's biggest Q4 2022 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.33M.
- Lindbrook Capital fully exited iShares ESG Aware MSCI USA ETF in Q4 2022, selling an estimated $215K.
- Lindbrook Capital's ten largest holdings make up 42% of its $812M portfolio in Q4 2022.
- Lindbrook Capital opened 215 new positions and closed 267 in Q4 2022.
- Lindbrook Capital's portfolio value rose 37% quarter-over-quarter to $812M.
Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.